428 related articles for article (PubMed ID: 15951398)
21. Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity.
Nagai N; Hotta K; Yamamura H; Ogata H
Cancer Chemother Pharmacol; 1995; 36(5):404-10. PubMed ID: 7634382
[TBL] [Abstract][Full Text] [Related]
22. Quantification of sodium thiosulphate protection on cisplatin-induced toxicities.
Leitao DJ; Blakley BW
J Otolaryngol; 2003 Jun; 32(3):146-50. PubMed ID: 12921131
[TBL] [Abstract][Full Text] [Related]
23. [The clinical and pharmacokinetic evaluation of two-route chemotherapy with cisplatin and sodium thiosulfate in combination with angiotensin II].
Takizawa K; Harada M; Fujimaru J; Matsushiro N; Shima Y; Andoh I; Satoh M; Yokoo I; Iguchi T; Hirabayashi K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):595-602. PubMed ID: 1619320
[TBL] [Abstract][Full Text] [Related]
24. N-acetylcysteine improves renal hemodynamics in rats with cisplatin-induced nephrotoxicity.
Abdelrahman AM; Al Salam S; AlMahruqi AS; Al husseni IS; Mansour MA; Ali BH
J Appl Toxicol; 2010 Jan; 30(1):15-21. PubMed ID: 19681060
[TBL] [Abstract][Full Text] [Related]
25. First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate.
Neuwelt EA; Brummett RE; Doolittle ND; Muldoon LL; Kroll RA; Pagel MA; Dojan R; Church V; Remsen LG; Bubalo JS
J Pharmacol Exp Ther; 1998 Jul; 286(1):77-84. PubMed ID: 9655844
[TBL] [Abstract][Full Text] [Related]
26. Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors.
Doolittle ND; Muldoon LL; Brummett RE; Tyson RM; Lacy C; Bubalo JS; Kraemer DF; Heinrich MC; Henry JA; Neuwelt EA
Clin Cancer Res; 2001 Mar; 7(3):493-500. PubMed ID: 11297239
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model.
Neuwelt EA; Pagel MA; Kraemer DF; Peterson DR; Muldoon LL
J Pharmacol Exp Ther; 2004 May; 309(2):594-9. PubMed ID: 14752063
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
[TBL] [Abstract][Full Text] [Related]
29. Effect of sodium thiosulfate on cisplatin removal after intra-arterial embolization with a lipiodol-platinum suspension for hepatocellular carcinoma.
Tamura Y; Ikeda O; Nakasone Y; Iryo Y; Yamashita Y
Acta Radiol; 2010 May; 51(4):383-8. PubMed ID: 20192896
[TBL] [Abstract][Full Text] [Related]
30. Increased therapeutic effect on metastatic liver tumors in rats of two-route chemotherapy using cis-diamminedichloroplatinum (II) and its antidote, sodium thiosulfate, with temporary clamping of the abdominal aorta.
Hasuda K; Kobayashi H; Aoki K; Taniguchi S; Baba T
Cancer Chemother Pharmacol; 1990; 26(3):181-7. PubMed ID: 2357764
[TBL] [Abstract][Full Text] [Related]
31. Effects of cis-diamminedichloroplatinum(II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture.
Tay LK; Bregman CL; Masters BA; Williams PD
Cancer Res; 1988 May; 48(9):2538-43. PubMed ID: 2965614
[TBL] [Abstract][Full Text] [Related]
32. Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption.
Neuwelt EA; Gilmer-Knight K; Lacy C; Nicholson HS; Kraemer DF; Doolittle ND; Hornig GW; Muldoon LL
Pediatr Blood Cancer; 2006 Aug; 47(2):174-82. PubMed ID: 16086410
[TBL] [Abstract][Full Text] [Related]
33. Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats.
González R; Romay C; Borrego A; Hernández F; Merino N; Zamora Z; Rojas E
Mediators Inflamm; 2005 Aug; 2005(3):139-43. PubMed ID: 16106099
[TBL] [Abstract][Full Text] [Related]
34. [Studies on an appropriate intra thoracic administration of cisplatin and sodium thiosulfate in malignant pleural effusion].
Kitajima K; Fukuoka M; Kusunoki Y; Negoro S; Takada M; Matsui K; Sakai N; Ryu S; Takifuji N; Masuda N
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3253-9. PubMed ID: 3196043
[TBL] [Abstract][Full Text] [Related]
35. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats.
Mohan IK; Khan M; Shobha JC; Naidu MU; Prayag A; Kuppusamy P; Kutala VK
Cancer Chemother Pharmacol; 2006 Dec; 58(6):802-8. PubMed ID: 16552571
[TBL] [Abstract][Full Text] [Related]
36. Protective effect of dietary azuki bean (Vigna angularis) seed coats against renal interstitial fibrosis of rats induced by cisplatin.
Sato S; Hori Y; Yamate J; Saito T; Kurasaki M; Hatai A
Nutrition; 2005 Apr; 21(4):504-11. PubMed ID: 15811772
[TBL] [Abstract][Full Text] [Related]
37. In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity.
Neuwelt EA; Brummett RE; Remsen LG; Kroll RA; Pagel MA; McCormick CI; Guitjens S; Muldoon LL
Cancer Res; 1996 Feb; 56(4):706-9. PubMed ID: 8630999
[TBL] [Abstract][Full Text] [Related]
38. Chrysin protects against cisplatin-induced colon. toxicity via amelioration of oxidative stress and apoptosis: probable role of p38MAPK and p53.
Khan R; Khan AQ; Qamar W; Lateef A; Tahir M; Rehman MU; Ali F; Sultana S
Toxicol Appl Pharmacol; 2012 Feb; 258(3):315-29. PubMed ID: 22155348
[TBL] [Abstract][Full Text] [Related]
39. Acceleration of cisplatin ototoxicity by perilymphatic application of 4-methylthiobenzoic acid.
Cappaert NL; Klis SF; Wijbenga J; Smoorenburg GF
Hear Res; 2005 May; 203(1-2):80-7. PubMed ID: 15855032
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacokinetics of cisplatin and the effect of sodium thiosulfate].
Hayata S; Hitoshi T; Kiyokawa K; Esaki S; Mihashi S; Hirano M
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2356-61. PubMed ID: 6541891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
